SM 324405

CAS No. 677773-91-0

SM 324405( —— )

Catalog No. M21108 CAS No. 677773-91-0

SM 324405 is an agonist of TLR7.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 106 Get Quote
10MG 172 Get Quote
25MG 321 Get Quote
50MG 509 Get Quote
100MG 731 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SM 324405
  • Note
    Research use only, not for human use.
  • Brief Description
    SM 324405 is an agonist of TLR7.
  • Description
    SM 324405 is an agonist of TLR7.
  • In Vitro
    SM-324405 is a novel candidate for immunotherapy of allergic diseases.
  • In Vivo
    SM-324405 (9e, intratracheal administration) effectively inhibits allergen-induced airway inflammation without inducing cytokines systemically.SM-324405 is metabolized to the corresponding acid in human plasma with t1/2 of 2.6 min.
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    TLR
  • Recptor
    TLR7
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    677773-91-0
  • Formula Weight
    385.42
  • Molecular Formula
    C19H23N5O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (129.73 mM)
  • SMILES
    CCCCOc1nc(N)c2[nH]c(=O)n(Cc3cccc(CC(=O)OC)c3)c2n1
  • Chemical Name
    Methyl 3-[(6-amino-2-butoxy-78-dihydro-8-oxo-9H-purin-9-yl)methyl]benzeneacetate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kurimoto A Hashimoto K Nakamura T.Synthesis and biological evaluation of 8-oxoadenine derivatives as toll-like receptor 7 agonists introducing the antedrug concept[J].J Med Chem. 2010 Apr 8 ;53(7):2964-72.
molnova catalog
related products
  • CU CPT 4a

    CU CPT 4a is a selective TLR3 inhibitor (IC50: 3.44 μM in RAW 264.7 cells).

  • SM360320

    SM360320 is an effective and selective agonist of TLR7. SM360320 inhibits HCV replication in hepatocytes via a type I IFN-independent mechanism in addition to its IFN-mediated activity.

  • Enpatoran

    Enpatoran is an inhibitor of TLR7(IC50 = 11.1 nM) and TLR8(IC50 = 24.1 nM). Enpatoran was found to be inactive against TLR3, TLR4, and TLR9 in vitro and in vivo.